Abstract：Objective To investigate the clinical therapeutic effect of Valsartan in the treatment of essential hypertension,the improvement of ambulatory blood pressure and the safety of treatment.Methods Forty-eight patients with primary hypertension admitted to our hospital from October 2015 to October 2017 were selected and divided into observation group and control group according to random number table method,24 cases in each group.The patients in the observation group were given Ammonia Chloride 5 mg/d plus Valsartan 80 mg/d,the control group received Amlodipine 5 mg/d,the two groups were treated for 5 months,the treatment of total effective rate,ambulatory blood pressure monitoring and incidence of adverse reactions were compared detween the two groups.Results The total effective rate of treatment in the observation group (95.83%)was significantly higher than that in the control group (70.83%),and the difference was statistically significant(P<0.05).The 24-hour systolic blood pressure (SBP),24-hour systolic blood pressure variability (SBPV),24-hour diastolic blood pressure (DBP),and 24-hour diastolic blood pressure variability(DBPV)were significantly lower in the observation group than in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the overall incidence of adverse reactions between the two groups(P＞0.05).Conclusion The clinical effect of valsartan in the treatment of essential hypertension is clear,it can positively improve the blood pressure status of patients,and it is safe and worthy of clinical application.
曾贤鑫. 缬沙坦辅助治疗原发性高血压的可行性及安全性[J]. 中国当代医药, 2019, 26(16): 35-37.
ZENG Xian-xin. Feasibility and safety of Valsartan in the treatment of essential hypertension. 中国当代医药, 2019, 26(16): 35-37.
京公网安备 11010502046607号